T42.6X5A

Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter

The ICD-10-CM code T42.6X5A refers to an adverse effect resulting from the correct administration of prescribed antiepileptic or sedative-hypnotic medications that fall outside the categories of hydantoins, iminostilbenes, succinimides, barbiturates, or benzodiazepines. This includes modern therapeutic agents such as gabapentin, pregabalin, levetiracetam, topiramate, and valproic acid derivatives. An adverse effect is distinguished from poisoning because the medication was taken as directed by a healthcare provider, but the patient experienced an unintended, harmful reaction. The 'initial encounter' (A) designation indicates that the patient is currently receiving active treatment for this reaction, which may include emergency department evaluation, acute hospitalization, or initial surgical intervention for complications. Clinical management focuses on symptom stabilization, dose adjustment, or discontinuation of the offending agent while monitoring for potential withdrawal or recurrence of the underlying seizure or sleep disorder.

Clinical Symptoms

Dizziness and lightheadedness
Somnolence or excessive daytime sleepiness
Ataxia and impaired coordination
Peripheral edema (commonly associated with gabapentinoids)
Cognitive impairment or 'brain fog'
Blurred or double vision (diplopia)
Weight gain or increased appetite
Nausea and gastrointestinal distress
Irritability or mood fluctuations
Tremors or involuntary movements
Hepatotoxicity (primarily associated with valproate)
Rash or dermatological reactions (ranging from mild to Stevens-Johnson Syndrome)
Leukopenia or thrombocytopenia

Common Causes

Idiosyncratic drug reactions to newer antiepileptic agents
Polypharmacy leading to synergistic CNS depression
Impaired renal clearance (especially for gabapentin and levetiracetam)
Hepatic metabolic dysfunction (affecting valproate and topiramate metabolism)
Genetic predisposition to drug hypersensitivity (e.g., HLA-B*1502 allele)
Age-related changes in drug distribution and metabolism in elderly populations
Rapid titration of medication dose beyond patient tolerance
Drug-drug interactions with other sedative medications or alcohol

Documentation & Coding Tips

Distinguish between adverse effect and poisoning for accurate selection of the 5th character.

Example: Patient with epilepsy presents with new-onset ataxia and slurred speech while taking levetiracetam exactly as prescribed. This is an adverse effect (T42.6X5A) rather than a poisoning (T42.6X1A), as the drug was taken correctly. Clinical documentation must explicitly state the drug was taken as directed to support this code.

Billing Focus: Identify the 5th character as 5 for adverse effect and ensure the 7th character is A for the initial encounter where active treatment is provided.

Document the specific manifestation resulting from the drug ingestion.

Example: Patient reports significant peripheral edema and weight gain of 5 lbs since starting pregabalin for post-herpetic neuralgia 2 weeks ago. Diagnosis: Adverse effect of other antiepileptics (T42.6X5A), Manifestation: Localized edema (R60.0). Note reflects the causal link between medication start date and symptom onset.

Billing Focus: Sequence the manifestation code immediately following the T42.6X5A code to provide a complete clinical picture for reimbursement.

Explicitly identify the specific antiepileptic or sedative-hypnotic agent.

Example: Patient taking topiramate 100mg BID for migraine prophylaxis presents with acute cognitive slowing and word-finding difficulties. Documentation specifies topiramate as the causative agent for the adverse effect (T42.6X5A). Cognitive impairment (R41.841) is documented as the resulting manifestation.

Billing Focus: Documentation of the specific drug allows for more granular internal data tracking even though the ICD-10 code covers a group of other antiepileptics.

Specify the encounter type as initial, subsequent, or sequela.

Example: This is the initial evaluation in the emergency department for a patient experiencing visual hallucinations after starting zonisamide. Documentation confirms T42.6X5A as the primary code for this active treatment phase.

Billing Focus: Use 7th character A for the initial encounter, which includes any encounter where the patient is receiving active treatment for the condition.

Note the intended therapeutic use of the medication.

Example: Patient on lacosamide for focal seizures presents with PR interval prolongation on EKG. The drug was used for its intended purpose (seizure control) and administered at the recommended dose. Diagnosis: Adverse effect of other antiepileptic (T42.6X5A) with EKG abnormality (R94.31).

Billing Focus: Establishing that the drug was used for a therapeutic purpose is essential to validate the use of an adverse effect code over a poisoning code.

Relevant CPT Codes

99203 - Office or other outpatient visit for the evaluation and management of a new patient
Used for new patients presenting with minor adverse reactions requiring straightforward diagnosis and management changes.
99204 - Office or other outpatient visit for the evaluation and management of a new patient
Appropriate for new patients with complex adverse effects requiring medication cessation and coordination of care.
99213 - Office or other outpatient visit for the evaluation and management of an established patient
Standard for monitoring stable patients who develop mild adverse effects during routine follow-up.
99214 - Office or other outpatient visit for the evaluation and management of an established patient
Used when an adverse effect significantly complicates the management of an established patient's chronic condition.
99215 - Office or other outpatient visit for the evaluation and management of an established patient
Used for severe adverse effects that may be life-threatening or require urgent diagnostic evaluation.
80339 - Antiepileptics, 1-3
To determine serum levels of the drug to confirm toxicity or adverse reaction levels.
93000 - Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
Certain antiepileptics can cause cardiac conduction issues; an EKG is used to assess cardiac manifestations.
99283 - Emergency department visit for the evaluation and management of a patient
Common for patients presenting to the ER with acute drug-induced ataxia or confusion.
82374 - Carbon dioxide (bicarbonate)
Essential for monitoring metabolic acidosis associated with drugs like topiramate.
99285 - Emergency department visit for the evaluation and management of a patient
Reserved for unstable patients with severe drug-induced status changes or systemic toxicity.